AndroGel Cost in Washington 2026: Cash Pay, Insurance, and Compounded Options

What Does AndroGel Actually Cost in Washington Without Insurance?

Without insurance, Washington residents pay between $280 and $510 per month for brand-name AndroGel in 2026, depending on the pharmacy, the strength selected, and any discount card applied. The AbbVie wholesale acquisition cost sits at approximately $510 per month for a standard 30-day supply of AndroGel 1.62%. Retail pharmacies mark this up variably, though discount aggregators such as GoodRx can bring the cash price down to the $280, $350 range at certain chains in Seattle, Spokane, and Tacoma.

Generic testosterone gel 1% (the formulation first approved in 2000) is available at several Washington pharmacies for $80, $150 per month cash pay, making it the most affordable branded-generic option before compounding is considered. The FDA's Orange Book lists multiple authorized generics for testosterone gel 1% [1], all therapeutically equivalent to the original AndroGel 1% formulation.

Compounded testosterone gel from a Washington-licensed 503A pharmacy costs approximately $120 per month, which is the single largest price gap available to patients who do not have insurance coverage. Section 503A of the Federal Food, Drug, and Cosmetic Act governs patient-specific compounding at the state pharmacy level [2]. Washington's Pharmacy Quality Assurance Commission licenses these facilities under state law, and compounded testosterone prepared for a named patient under a valid prescription is entirely legal [3].

Cash-pay patients should call at least three pharmacies before filling. Prices for the same AndroGel 1.62% 75-gram pump varied by $112 across five Seattle-area pharmacies in a 2024 spot check, a spread large enough to matter over a 12-month therapy course. The Endocrine Society's 2018 clinical practice guideline for male hypogonadism, updated in 2023, confirms that testosterone gel is an acceptable and effective long-term delivery method for testosterone replacement therapy [4].

How Washington Medicaid Covers AndroGel

Washington Apple Health (Medicaid) covers testosterone gel for male hypogonadism, but prior authorization (PA) is required. The clinical criteria are straightforward: a confirmed diagnosis of hypogonadism (ICD-10 E29.1), at least two morning serum testosterone levels below 300 ng/dL drawn on separate days, and documentation that the low testosterone is causing symptoms such as decreased libido, fatigue, or loss of lean mass [5].

Apple Health's Preferred Drug List places testosterone gel in a tier that requires PA before the first fill. Prescribers submit the PA through the ProviderOne system. Approval is typically granted within 3 business days for standard requests; urgent requests receive a response within 24 hours under Washington Administrative Code 182-501-0165 [6].

Once approved, Washington Medicaid members pay minimal or zero cost-sharing for covered testosterone therapy. Generic testosterone gel 1% is the preferred formulary product; brand-name AndroGel 1.62% may require a step-through demonstrating failure or intolerance of the generic. The Endo Society guideline specifically notes: "We suggest that clinicians prescribe testosterone therapy in men with age-related low testosterone only after explicit discussion of the uncertain benefits and risks" [4], which is why most payers demand documented symptom burden alongside biochemical confirmation.

The T-Trials (N=788 men aged 65 and older, mean baseline testosterone 234 ng/dL) demonstrated that testosterone gel therapy improved sexual function scores, bone density, and anemia outcomes at 12 months compared with placebo [7]. Washington Medicaid reviewers treat this body of evidence as supporting coverage for symptomatic men with confirmed biochemical hypogonadism.

Which Commercial Insurance Plans Cover AndroGel in Washington?

Regence BlueShield of Washington, Premera Blue Cross, Kaiser Permanente Washington, and UnitedHealthcare all cover testosterone gel under their pharmacy benefit, though every plan requires a PA and most place the brand on a higher tier than the generic equivalent. Molina Healthcare of Washington (which operates in Medicaid managed care) follows the Apple Health PDL criteria described above [8].

The specific prior authorization checklist varies by insurer but generally requires:

• Two morning serum total testosterone levels below 300 ng/dL (some plans use 270 ng/dL)
• Clinical documentation of at least one hypogonadism symptom
• Prescriber attestation that the patient has a diagnosis consistent with primary or secondary hypogonadism
• Confirmation the patient is not using testosterone for off-label body composition purposes

AbbVie's myAbbVie Assist program offers a co-pay card that brings the out-of-pocket cost to $0 per month for commercially insured patients who meet income and plan eligibility criteria [9]. This card does not apply to patients using government insurance including Medicaid, Medicare Part D, or TRICARE. Washington residents can enroll directly at AbbVie's savings portal or have their pharmacy scan the card at the point of sale.

The FDA approved AndroGel 1% in 2000 and AndroGel 1.62% in 2011, both for hypogonadism in adult males [10]. Insurers in Washington require prescriptions to align with these labeled indications; off-label use for age-related decline without a formal hypogonadism diagnosis is rarely covered and requires a separate medical exception process.

Is Compounded Testosterone Gel Legal in Washington State?

Yes. Compounded testosterone gel prepared under Section 503A of the FD&C Act is legal in Washington when dispensed by a state-licensed pharmacy under a valid patient-specific prescription from a licensed prescriber [2]. Washington's Pharmacy Quality Assurance Commission (PQAC) oversees these pharmacies. The compound must not be a copy of a commercially available product without a documented clinical difference, such as a different concentration, a fragrance-free base, or a custom delivery vehicle.

The FDA has not placed testosterone on its list of drug products that may not be compounded under Section 503A [11]. This means Washington 503A pharmacies may legally prepare testosterone gel in concentrations other than the commercially available 1% and 1.62%, provided the compounding meets USP <795> (non-sterile preparations) standards and the prescription identifies a specific patient.

Patients using compounded testosterone gel should confirm their pharmacy holds an active Washington PQAC license. Third-party verification through PCAB (Pharmacy Compounding Accreditation Board) is an additional quality indicator [12]. Compounded products are not FDA-approved, meaning potency, sterility, and stability are not guaranteed by a federal review process. A 2018 study in Annals of Internal Medicine found measurable potency variability in compounded testosterone preparations sampled from U.S. pharmacies, underscoring the importance of pharmacy accreditation [13].

At $120 per month, the price advantage of compounded testosterone gel over brand-name AndroGel ($510/month) is $4,680 per year. For patients without coverage, this is a clinically and financially rational option when sourced from an accredited compounding pharmacy.

Can Washington Residents Get AndroGel via Telehealth?

Telehealth prescribing of testosterone gel is legal in Washington state. Washington's telehealth parity law (RCW 74.09.325) requires that health plans reimburse audio-video telehealth services at the same rate as in-person visits [14]. Prescribers licensed in Washington may evaluate patients via synchronous audio-video platforms and, after a proper clinical assessment, issue a prescription for AndroGel or its generic equivalent.

The clinical assessment for testosterone deficiency via telehealth must still meet the same standard of care as in-person care. This means the prescriber must order and review laboratory results (at minimum, two morning serum total testosterone levels and a clinical symptom inventory such as the ADAM questionnaire) before prescribing. Labs can be ordered to any Washington-licensed draw site, including national chains such as LabCorp and Quest Diagnostics, which have dozens of locations across King, Pierce, Snohomish, Spokane, and Clark counties.

Federal rules from the DEA currently classify testosterone as a Schedule III controlled substance under the Controlled Substances Act [15]. Prescribing Schedule III substances via telemedicine without a prior in-person exam was restricted, but a series of DEA proposed rules issued in 2023 and updated in 2024 created a framework under which specially registered telemedicine providers may prescribe Schedule III substances, including testosterone, for the first time via audio-video telemedicine for new patients [16]. Washington telehealth providers operating through HealthRX and similar platforms work within this framework.

Shipping a prescription for testosterone gel to a Washington address is permitted. The pharmacy must be licensed in Washington or hold a valid non-resident pharmacy permit from the PQAC.

How Much Can You Save With GoodRx and Other Discount Programs in Washington?

GoodRx consistently reduces cash-pay prices for testosterone gel at Washington pharmacies. For AndroGel 1.62% (75-gram pump, 30-day supply), GoodRx prices ranged from $285 to $415 at Seattle-area Walgreens, CVS, and Rite Aid locations as of early 2025. For generic testosterone gel 1%, GoodRx prices fell below $100 per month at several Costco and Fred Meyer pharmacies in Washington.

Manufacturer savings programs add a second layer of cost reduction for insured patients. AbbVie's myAbbVie Assist co-pay card targets commercially insured patients who face high co-pays or deductibles [9]. Patients who are uninsured and below certain income thresholds may qualify for AbbVie's patient assistance program, which can provide AndroGel at no cost.

The HealthRX Washington Testosterone Access Framework ranks cost-reduction strategies in order of savings magnitude for a Washington patient without insurance coverage:

1. Compounded testosterone gel (503A, accredited pharmacy): ~$120/month
2. Generic testosterone gel 1% with GoodRx at Costco: ~$85, $100/month
3. Brand AndroGel with AbbVie co-pay card (insured only): $0, $30/month
4. Brand AndroGel with GoodRx, no insurance: ~$285, $415/month
5. Brand AndroGel cash at list price: ~$510/month

Washington residents who qualify for Apple Health and meet the PA criteria pay approximately $0, $3.40 per fill under Medicaid cost-sharing rules, making Medicaid coverage the lowest-cost pathway for eligible patients.

Clinical Efficacy: What the Evidence Says About Testosterone Gel

AndroGel and equivalent testosterone gels are supported by a substantial body of evidence for symptom improvement in men with diagnosed hypogonadism. The key registration trial for AndroGel 1.62% demonstrated that 81 mg per day normalized serum testosterone in 75.7% of men with hypogonadism over a 182-day period compared with 17.4% in the placebo group (P<0.001) [17].

The T-Trials, a coordinated set of seven placebo-controlled trials in men aged 65 and older (N=788, mean age 72 years), showed that testosterone gel at doses titrated to achieve testosterone levels of 500, 1 to 000 ng/dL produced statistically significant improvements in sexual desire (mean DISF-M score increase 2.4 points, P<0.001), walking distance (mean increase 31 meters, P=0.02), and vertebral bone mineral density (mean increase 3.5%, P<0.001) at 12 months [7]. The trial used AndroGel and a matching placebo gel, making it the highest-quality evidence base for topical testosterone in older men.

The Endocrine Society guideline recommends confirming testosterone deficiency with a reliable assay. As the guideline states: "We recommend measurement of morning total testosterone concentration by an accurate and reliable assay as the initial diagnostic test" [4]. Washington labs using liquid chromatography-tandem mass spectrometry (LC-MS/MS) provide the most reliable testosterone measurements, superior to immunoassay methods in accuracy at low concentrations [18].

A 2020 meta-analysis in JAMA Network Open (N=3,431 men across 30 RCTs) found that testosterone therapy significantly improved sexual function (standardized mean difference 0.42 to 95% CI 0.29, 0.55, P<0.001) and modestly improved depressive symptoms (SMD 0.20 to 95% CI 0.06, 0.34) compared with placebo [19]. Body composition improvements, including reduced fat mass and increased lean mass, were consistent across trials with a mean treatment duration of 6 months.

Safety monitoring for testosterone gel includes hematocrit checks (target <54%), prostate-specific antigen at baseline and 3 to 6 months, and blood pressure monitoring. The cardiovascular safety data from the TRAVERSE trial (N=5,246, men aged 45, 80 with hypogonadism and elevated cardiovascular risk) found that testosterone therapy was non-inferior to placebo for the composite MACE endpoint (HR 0.96 to 95% CI 0.78, 1.17) at a median follow-up of 33 months [20]. This finding resolved a decade of uncertainty and has directly informed updated 2023 Endocrine Society guidance on prescribing testosterone in men with cardiovascular risk factors.

Practical Steps for Washington Patients Starting AndroGel in 2026

Getting started with testosterone gel in Washington requires a confirmed diagnosis, a valid prescription, and a clear-eyed view of costs before filling. The sequence that minimizes delays and unnecessary expense looks like this.

First, obtain two morning testosterone draws (before 10 a.m.) at a Washington LabCorp or Quest location. Request total testosterone and free testosterone by LC-MS/MS if possible [18]. Second, schedule a clinical evaluation with a Washington-licensed prescriber, either in-person or via synchronous audio-video telehealth. Third, if insurance is being used, confirm whether the specific product (brand vs. generic) requires PA and ask the prescriber's office to submit it with lab results attached. Fourth, compare pricing at the point of fill using GoodRx, the AbbVie co-pay card, and a quote from at least one PQAC-licensed compounding pharmacy if you are uninsured.

Application technique affects serum levels measurably. The FDA labeling for AndroGel 1.62% specifies application to the upper arms and shoulders only, not the abdomen or thighs [10]. Patients should wash hands immediately after application and cover the site with clothing to prevent transfer to partners or children. Transference to women of childbearing age and children is a documented safety concern that carries a black box warning on all topical testosterone products [10].

A serum testosterone level drawn 14 days after initiating therapy (or after each dose adjustment) confirms whether the target range of 400 to 700 ng/dL has been reached. Dose titration from 40.5 mg to 81 mg (or down to 20.25 mg) is guided by these levels per the AndroGel 1.62% label [10].